A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy

NCT01691989 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

197

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: aleglitazar
DRUG: placebo

Sponsor

Hoffmann-La Roche